Family Sues After Michigan Girl, 17, Denied Kidney Transplant for Refusing Shots
May 13, 2022 18:55 ET
|
We The Patriots USA, Inc.
GRAND RAPIDS, Mich., May 13, 2022 (GLOBE NEWSWIRE) -- A federal lawsuit has been filed in the Western District of Michigan against Spectrum Health Hospitals/Helen Devos Children's Hospital today, on...
World’s largest kidney stone patient experience survey finds 60% of respondents experienced first kidney stone before the age of 45
February 07, 2022 04:04 ET
|
Advanced MedTech
Singapore, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dornier MedTech publishes new insights on World Kidney Stone Day from its digital urology community which garners 45 million patient and...
American Kidney Fund Accredits and Redesigns Kidney Health Coach Program for Professional Audiences
January 13, 2022 14:28 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 13, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announces its revamped and redesigned Kidney Health Coach community education program. Originally launched in...
Urinalysis Market Size ($5,937.97Mn by 2028) Lead by Sediment Urinalysis Test (5.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 21, 2021 11:03 ET
|
The Insight Partners
New York, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The new research study on the Urinalysis Market Size and Forecast to 2028 By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility...
Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET
|
Angion Biomedica Corp.
-- Topline data in ANG-3777 Phase 3 study now expected to be announced in early Q4 rather than at year end -- Phase 1 data demonstrated ANG-3070 was well-tolerated across dose cohorts, achieving drug...
Angion Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3070 and FDA Authorization to Initiate Phase 2 Trial in 2021
August 03, 2021 00:05 ET
|
Angion Biomedica Corp.
ANG-3070 was well-tolerated across dose cohorts, achieving drug exposures in humans exceeding exposures in which activity was demonstrated in animal models of proteinuric kidney...
Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
March 30, 2021 16:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Kidney Dialysis Market Value Projected To Reach US$ 96.5 Billion By 2027: Acumen Research And Consulting
March 23, 2021 10:02 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Kidney Dialysis Market – Global Industry Analysis, Market Size, Opportunities and...
Angion to Participate in Upcoming March Investment Conferences
February 24, 2021 00:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Renibus Therapeutics Announces Publication of Positive Results of RBT-3 Experimental Preclinical Studies in Scientific Journal Nephrology Dialysis Transplant
February 16, 2021 09:00 ET
|
Rénibus Therapeutics Inc.
-With no currently approved therapies for the prevention or treatment of platinum-induced toxicity, RBT-3 has the potential to fill a critical unmet medical need Dallas, Texas, Feb. 16, 2021 ...